Weight-Loss Drugs’ Hidden Nutrient Deficiency Risk

three women in gymwear looking at a smartphone
Photo: Bojan Milinkov / Shutterstock

Millions of Americans on Ozempic, Wegovy, or Zepbound eat so much less that doctors are now watching for a quiet side effect: vitamin B12 running low.

Quick Take

  • GLP-1 drugs do not block B12 absorption the way metformin does, but eating less food can still create a shortage over time.
  • No major medical group tells every GLP-1 user to take a B12 supplement automatically.
  • Doctors say blood tests, not blanket pill-popping, should guide the decision.
  • People eating little meat, losing weight fast, or feeling foggy and tired face the highest risk.

Why These Drugs Create A Nutrient Blind Spot

GLP-1 medications work by slowing digestion and killing appetite. That is the whole point, and it is why they help people lose serious weight. But Dr. Chung, quoted in Men’s Health, explains that nutrient gaps come from “a combination of eating less food, eating less dietary variety, delayed gastric emptying, and rapid weight loss”. B12 is not absorbed less efficiently because of the drug itself. It just becomes harder to get enough of it from food.

That distinction matters. Metformin, a common diabetes drug, physically interferes with how the gut binds B12. GLP-1 drugs do not do that. The risk here is indirect, driven by smaller portions and less variety on the plate, not by the medication messing with absorption machinery in the intestine.

What The Research Actually Shows So Far

A retrospective claims study tracking over 461,000 adults on GLP-1 drugs found nutritional deficiency diagnoses rising over time, reaching notable levels by the one-year mark. A review in the journal Nutrients points out that GLP-1 users do not experience the same surgical malabsorption seen in bariatric surgery patients, yet reduced intake and appetite suppression can still chip away at vitamin stores over months of treatment.

Still, the same review stops short of a blanket recommendation. It states plainly that “routine laboratory screening and universal micronutrient supplementation cannot currently be recommended for all individuals” on these drugs. Instead, it calls for judging each patient by diet, weight-loss speed, other medications, and symptoms like fatigue or nerve tingling before reaching for a bottle of B12.

Why Doctors Resist A One-Size-Fits-All Answer

Dr. Chung’s own guidance reflects that caution. She calls a B12 supplement “worth considering” for GLP-1 users but stresses it is “not a requirement,” adding that doctors may order blood tests first to confirm a real deficiency before changing diet or adding pills. That is a sensible, grown-up approach. It treats patients as individuals instead of handing out a supplement like a party favor to anyone who fills an Ozempic prescription.

A separate review of incretin-based drugs backs that approach, stating that “current evidence does not support universal routine supplementation” but that targeted use “may be reasonable” when intake is poor, risk is high, or lab work already shows a problem. The National Institutes of Health’s own fact sheet adds a useful tool here, noting that a follow-up test called methylmalonic acid can confirm a deficiency when B12 blood levels fall into a gray zone rather than a clear-cut low reading.

Who Actually Needs To Pay Attention

Physicians commenting online echo the same theme: target, don’t blanket. Dr. Almerie recommends B12 specifically for vegetarians or people losing weight fast who report fatigue or brain fog, while warning against supplements that do not solve a real problem in the body. Dr. Bazgha Khalid similarly points to multivitamins as a way to patch general gaps from eating less, paired with lab testing rather than guesswork.

The practical takeaway for anyone on these drugs is straightforward. Watch for warning signs like numbness, tingling, exhaustion, or memory fog. Mention them to your doctor instead of self-diagnosing off a video or article. Ask about a simple blood test before buying a supplement you may not need. And remember that food variety, especially protein sources, still matters even when your appetite has shrunk to almost nothing.

This fits a broader pattern many have long pushed on health policy: individualized medicine beats one-size-fits-all mandates, whether the subject is vaccines, diet guidelines, or vitamin pills. The evidence here supports exactly that approach. Doctors should test, not guess, and patients deserve guidance tailored to their own risk rather than a marketing-driven rule applied to everyone on a popular drug.

Sources:

menshealth.com, ifso.com, womenshealthmag.com